Cytek BioSciences Inc
CTKB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$763.78M
Close$
$0.21
96.5% downside
Current Fair Value
96.5% downsideOvervalued by 96.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $763.78 Million |
|---|---|
| Enterprise Value | $751.94 Million |
| Earnings per Share | $-0.52 |
| Beta | 1.14 |
| Outstanding Shares | 130,358,484 |
Return
| Return on Equity | -25.27% |
|---|---|
| Return on Assets | -18.20% |
| Return on Invested Capital | -11.01% |
Valuation & Multiples
| P/E Ratio | -9.27 |
|---|---|
| PEG | -82.04 |
| Price to Sales | 5.84 |
| Price to Book Ratio | 2.92 |
| Enterprise Value to Revenue | 3.62 |
| Enterprise Value to EBIT | -18.9 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 4, 2026
EPS
-$0.05
Est. -$0.07Revenue
$53.23 M
Est. $53.05 MNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-$0.04
Consensus analyst estimateRevenue Estimate
$63.38 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.28%▼ 56.56% |
|---|---|
| Total Invested | $56.04M▼ 84.69% |
| Investors Holding | 47▼ 109.00% |
About Cytek BioSciences Inc
2,021 employees
